Literature DB >> 22588647

Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools.

Gemma Strickland1, John Pauling, Charlotte Cavill, Neil McHugh.   

Abstract

This study evaluates predictors of health-related quality of life (HRQoL) and fatigue in systemic sclerosis (SSc) using two novel self-report indices. A cross-sectional study of patients with SSc was undertaken using a postal questionnaire including the EuroQol-5Domain health questionnaire (EQ-5D™), Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-F) and the Scleroderma Health Assessment Questionnaire (SHAQ). The EQ-5D assesses five domains of health quality and is quantified as a time trade-off (TTO) value and patient global assessment (0-100 visual analogue scale [VAS]). The FACIT-F is a 13-item questionnaire (0-52 scale). Higher scores for both the EQ-5D and FACIT-F indicate better health. Case notes were scrutinised for patient demographics, disease duration, serology and clinical phenotype. Sixty-eight patients (60 females, mean age 62.6 years) completed the questionnaires. Fatigue correlated closely with HRQoL (r (s) = 0.78 and 0.77 for FACIT-F vs. EQ-5D VAS and TTO respectively, p < 0.01) and disability (r (s) = -0.74 for FACIT-F vs. HAQ-DI, p < 0.01). Pain was the most frequently reported health problem (80 %) in the EQ-5D. HRQoL also correlated closely with disability (r (s) = 0.83 for EQ-5D vs. HAQ-DI, p < 0.01). SHAQ-VAS scores correlated well with the FACIT-F, EQ-5D and HAQ-DI scores (p < 0.05 for all comparisons). Of the patient demographics and clinical disease associations, only the absence of upper gastrointestinal complications was associated with better levels of fatigue, HRQoL and function. There is a strong correlation between disability, fatigue and HRQoL measured using self-reports, possibly reflecting similarly perceived health beliefs amongst patients across outcomes. There was little association between self-report indices and patient demographics and/or clinical phenotype.

Entities:  

Mesh:

Year:  2012        PMID: 22588647     DOI: 10.1007/s10067-012-1997-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

2.  Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis.

Authors:  Dewy van Hoogmoed; Jaap Fransen; Gijs Bleijenberg; Piet van Riel
Journal:  Rheumatology (Oxford)       Date:  2010-03-29       Impact factor: 7.580

3.  Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients.

Authors:  Brett D Thombs; Marie Hudson; Marielle Bassel; Suzanne S Taillefer; Murray Baron
Journal:  Arthritis Rheum       Date:  2009-07-15

4.  Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis.

Authors:  David Cella; Susan Yount; Mark Sorensen; Elliot Chartash; Nishan Sengupta; James Grober
Journal:  J Rheumatol       Date:  2005-05       Impact factor: 4.666

5.  Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.

Authors:  S B Yellen; D F Cella; K Webster; C Blendowski; E Kaplan
Journal:  J Pain Symptom Manage       Date:  1997-02       Impact factor: 3.612

6.  Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

Authors:  P J Clements; P A Lachenbruch; J R Seibold; B Zee; V D Steen; P Brennan; A J Silman; N Allegar; J Varga; M Massa
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

Review 7.  Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.

Authors:  Peter A Merkel; Philip J Clements; John D Reveille; Maria E Suarez-Almazor; Gabriele Valentini; Daniel E Furst
Journal:  J Rheumatol       Date:  2003-07       Impact factor: 4.666

8.  The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time.

Authors:  V D Steen; T A Medsger
Journal:  Arthritis Rheum       Date:  1997-11

9.  Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers.

Authors:  Angela Del Rosso; Maura Boldrini; David D'Agostino; Giovanni Plinio Augusto Placidi; Alessandra Scarpato; Alberto Pignone; Sergio Generini; Yrio Konttinen; Massimo Zoppi; Tonko Vlak; Gianfranco Placidi; Marco Matucci-Cerinic
Journal:  Arthritis Rheum       Date:  2004-06-15

10.  Association of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis.

Authors:  Christelle Nguyen; Alice Bérezné; Thierry Baubet; Caroline Mestre-Stanislas; François Rannou; Agathe Papelard; Sandrine Morell-Dubois; Michel Revel; Loïc Guillevin; Serge Poiraudeau; Luc Mouthon
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

View more
  15 in total

1.  Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality.

Authors:  Nicolas Richard; Marie Hudson; Mianbo Wang; Geneviève Gyger; Susanna Proudman; Wendy Stevens; Mandana Nikpour; Murray Baron
Journal:  Rheumatology (Oxford)       Date:  2019-04-01       Impact factor: 7.580

Review 2.  Fatigue in rheumatic diseases.

Authors:  Sevinç Can Sandıkçı; Zeynep Özbalkan
Journal:  Eur J Rheumatol       Date:  2015-09-01

Review 3.  Clinical significance and usefulness of rehabilitation for systemic sclerosis.

Authors:  Naoki Mugii; Yasuhito Hamaguchi; Susanna Maddali-Bongi
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

4.  Social/economic costs and health-related quality of life in patients with scleroderma in Europe.

Authors:  Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Panos Kanavos; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; Márta Péntek; Claudia Delgado; Johann Mathias von der Schulenburg; Ulf Persson; Karine Chevreul; Giovanni Fattore
Journal:  Eur J Health Econ       Date:  2016-04-02

5.  The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): an assessment of differential item functioning in patients with systemic sclerosis.

Authors:  Linda Kwakkenbos; Linda M Willems; Murray Baron; Marie Hudson; David Cella; Cornelia H M van den Ende; Brett D Thombs
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

6.  Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.

Authors:  Sébastien Peytrignet; Christopher P Denton; Mark Lunt; Roger Hesselstrand; Luc Mouthon; Alan Silman; Xiaoyan Pan; Edith Brown; László Czirják; Jörg H W Distler; Oliver Distler; Kim Fligelstone; William J Gregory; Rachel Ochiel; Madelon Vonk; Codrina Ancuta; Voon H Ong; Dominique Farge; Marie Hudson; Marco Matucci-Cerinic; Alexandra Balbir-Gurman; Øyvind Midtvedt; Alison C Jordan; Wendy Stevens; Pia Moinzadeh; Frances C Hall; Christian Agard; Marina E Anderson; Elisabeth Diot; Rajan Madhok; Mohammed Akil; Maya H Buch; Lorinda Chung; Nemanja Damjanov; Harsha Gunawardena; Peter Lanyon; Yasmeen Ahmad; Kuntal Chakravarty; Søren Jacobsen; Alexander J MacGregor; Neil McHugh; Ulf Müller-Ladner; Gabriela Riemekasten; Michael Becker; Janet Roddy; Patricia E Carreira; Anne Laure Fauchais; Eric Hachulla; Jennifer Hamilton; Murat Inanç; John S McLaren; Jacob M van Laar; Sanjay Pathare; Susanna Proudman; Anna Rudin; Joanne Sahhar; Brigitte Coppere; Christine Serratrice; Tom Sheeran; Douglas J Veale; Claire Grange; Georges-Selim Trad; Ariane L Herrick
Journal:  Rheumatology (Oxford)       Date:  2018-02-01       Impact factor: 7.580

7.  Common measure of quality of life for people with systemic sclerosis across seven European countries: a cross-sectional study.

Authors:  Mwidimi Ndosi; Begonya Alcacer-Pitarch; Yannick Allanore; Francesco Del Galdo; Marc Frerix; Sílvia García-Díaz; Roger Hesselstrand; Christine Kendall; Marco Matucci-Cerinic; Ulf Mueller-Ladner; Gunnel Sandqvist; Vicenç Torrente-Segarra; Tim Schmeiser; Matylda Sierakowska; Justyna Sierakowska; Stanslaw Sierakowski; Anthony Redmond
Journal:  Ann Rheum Dis       Date:  2018-02-20       Impact factor: 19.103

8.  Fatigue Predicts Future Reduced Social Participation, not Reduced Physical Function or Quality of Life in People with Systemic Sclerosis.

Authors:  Susan L Murphy; Daniel Whibley; Anna L Kratz; Janet L Poole; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2020-09-20

9.  Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability.

Authors:  Fausto Salaffi; Marina Carotti; Eleonora Di Donato; Marco Di Carlo; Luca Ceccarelli; Gianmarco Giuseppetti
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

10.  Predictors of health-related quality of life in musculoskeletal disease patients: a longitudinal analysis.

Authors:  Alfredo Madrid-García; Leticia León-Mateos; Esperanza Pato; Juan A Jover; Benjamín Fernández-Gutiérrez; Lydia Abasolo; Ernestina Menasalvas; Luis Rodríguez-Rodríguez
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-25       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.